Delivery Order SPE2DR25D3016-SPE2DR26FG2LP
- Not listed
- The Defense Logistics Agency awarded a $10,773.72 delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Lenvima 18 mg daily dose in a 90-day supply quantity. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be fulfilled from AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Lenvima 10 mg daily dose (30-count) with a ceiling value of $10,773.72. This is a firm fixed-price delivery order with no set-aside designation, representing a competitive award to the pharmaceutical distributor. The order is scheduled for completion by December 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $10,223.24 to AmerisourceBergen Drug Corp for the supply of Lenvima 8 mg daily dose in a quantity of 60 tablets. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 11, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made without a set-aside designation, reflecting open competition among eligible vendors. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Lenvima 8 mg daily dose tablets (60-count) with a ceiling value of $10,223.24. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The order is scheduled for completion by November 26, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the...
- The Defense Logistics Agency awarded a $10,223.24 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Lenvima 14 mg daily dose (60-count package), with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Lenvima 14 mg daily dose tablets (60-count package) valued at $29,732.85. This competitively awarded, firm fixed-price delivery order is scheduled for completion by June 24, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract contains no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $10,773.72 to AmerisourceBergen Drug Corp for the supply of Lenvima (8 mg daily dose, 60-count), a pharmaceutical product used in cancer treatment. This firm fixed-price delivery order, issued on November 17, 2025, with an ultimate completion date of December 9, 2025, represents a non-competitive set-aside transaction. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Lenvima 14 mg daily dose tablets (60-count units) with a contract ceiling value of $10,223.24. This firm fixed price delivery order, which is expected to be completed by September 9, 2025, represents a competitively awarded procurement with no set-aside designation. AmerisourceBergen Drug Corp will perform the work at its corporate office location in Conshohocken,...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $21,547.44 by the Defense Logistics Agency (DLA) on November 6, 2025, for the supply of LENVIMA 10 mg daily dose in quantities of 30 units. The contract is a firm fixed price delivery order with no set-aside designation, indicating competitive award through open competition. Performance will be fulfilled from the contractor's Conshohocken, Pennsylvania location, with an ultimate completion date of December 1, 2025. This award...
- The Defense Logistics Agency awarded a $10,223.24 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for Lenvima 8 mg daily dose tablets (60-count supply) with a completion deadline of August 20, 2025. This firm fixed price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award carries no set-aside designation, reflecting...
- SPE2DR25D3016Indefinite Delivery Contract
- SPE2DR25D3016-SPE2DR26FG2LPDelivery Order
This delivery order, awarded to AmerisourceBergen Drug Corp on December 19, 2025, establishes a $10,773.72 firm fixed-price contract for the supply of Lenvima 10 mg daily dose in 30-unit quantities. The award is a non-set-aside competitive procurement funded by the Defense Logistics Agency (DLA), a Department of Defense organization responsible for supplying pharmaceuticals and medical materiel to military healthcare systems. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of January 13, 2026. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive IDC serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of brand-name and generic medications, specialty pharmaceuticals, vaccines, and medical supplies to support military healthcare programs worldwide. The current delivery order for Lenvima, a oncology medication, exemplifies the company's role as a critical pharmaceutical distributor within the DLA's medical supply chain serving the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.8k | 12/18/25 |